✨
AI Summary
- Opus Genetics advances gene therapies for inherited retinal diseases.
- Focus on LCA5, a severe childhood blindness, using AAV-based subretinal delivery.
- Leveraging foundational science and legacy of Luxturna for new treatments.
Guests on This Episode
GM
George Magrath
1 podcast appearance